16.59
-0.83 (-4.76%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Beta Bionics, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -2.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.5 |
| Average | -0.61 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 6.51% |
| % Held by Institutions | 98.41% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FEIDER STEPHEN | - | 19.42 | -6,675 | -129,595 |
| HOPMAN MARK | - | 19.42 | -5,327 | -103,424 |
| MENSINGER MIKE | - | 19.42 | -4,375 | -84,941 |
| RUSSELL STEVEN JON | - | 19.42 | -4,221 | -81,951 |
| SAINT SEAN | - | 19.67 | -22,508 | -439,842 |
| Aggregate Net Quantity | -43,106 | |||
| Aggregate Net Value ($) | -839,752 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 19.50 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SAINT SEAN | Officer | 03 Sep 2026 | Automatic sell (-) | 5,641 | 19.92 | 112,369 |
| SAINT SEAN | Officer | 02 Sep 2026 | Sell (-) | 16,867 | 19.42 | 327,473 |
| FEIDER STEPHEN | Officer | 02 Sep 2026 | Sell (-) | 6,675 | 19.42 | 129,595 |
| RUSSELL STEVEN JON | Officer | 02 Sep 2026 | Sell (-) | 4,221 | 19.42 | 81,951 |
| HOPMAN MARK | Officer | 02 Sep 2026 | Sell (-) | 5,327 | 19.42 | 103,424 |
| MENSINGER MIKE | Officer | 02 Sep 2026 | Sell (-) | 4,375 | 19.42 | 84,941 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |